GeneXpert MTB/RIF version G4 for identification of Rifampin-resistant tuberculosis in a programmatic setting
Osman, Muhammad ORCID: https://orcid.org/0000-0003-3818-9729, Simpson, John A., Caldwell, Judy, Bosman, Marlein and Nicol, Mark P. (2014) GeneXpert MTB/RIF version G4 for identification of Rifampin-resistant tuberculosis in a programmatic setting. Journal of Clinical Microbiology, 52 (2). pp. 635-637. ISSN 0095-1137 (Print), 1098-660X (Online) (doi:10.1128/JCM.02517-13)
Preview |
PDF (Publisher VoR)
35535_OSMAN_GeneXpert_MTB_RIF_Version_G4.pdf - Published Version Available under License Creative Commons Attribution. Download (129kB) | Preview |
Abstract
A recent Cochrane review estimated GeneXpert MTB/RIF specificity for rifampin resistance as 98% (95% confidence interval [CI], 97 to 99), based on results from earlier test versions. The measured positive predictive value of the new generation test from programmatic implementation in Cape Town, South Africa, was 99.5% (95% CI, 98.5 to 100), confirming excellent specificity.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Xpert MTB/RIF; Rifampin-resistant; DR-TB programme |
Subjects: | Q Science > QA Mathematics > QA76 Computer software R Medicine > RS Pharmacy and materia medica |
Faculty / School / Research Centre / Research Group: | Faculty of Education, Health & Human Sciences Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM) |
Last Modified: | 22 Mar 2022 10:46 |
URI: | http://gala.gre.ac.uk/id/eprint/35535 |
Actions (login required)
View Item |
Downloads
Downloads per month over past year